AI Biopharma Playbook
The "AI_ON_STEROIDS" YouTube channel delivers sharp insights into AI innovations, biotech breakthroughs, and strategic technology trends. It features podcasts and videos aimed at showcasing how emerging technologies are reshaping industries. The channel is designed for a wide audience — including biotech investors, venture capitalists (VCs), startups, corporate firms, entrepreneurs, and technology enthusiasts — providing them with valuable perspectives to inform investment decisions, business strategies, and innovation roadmaps.
DISCLAIMER: Videos & commentary are not financial advice and should not be taken as financial advice. Videos are for information, education and entertainment purposes only.
For direct contact and negotiations, visit below link and leave me your thoughts on my email.
www.linkedin.com/in/sajad-sarvari-ph-d-mba-m-s-cls…
Sarvari.sajad@gmail.com,
AI Biopharma Playbook
Whether advancing a novel imaging platform, supporting medical device development, or contributing to commercialization strategy for novel therapeutics, I bring clarity, creativity, and cross-disciplinary leadership to every initiative.
Let’s connect if you’re passionate about translational science, biomedical product development, or driving innovation in life sciences.
4 months ago | [YT] | 0
View 0 replies
AI Biopharma Playbook
As a Six Sigma Green Belt and a business-savvy PhD, I combine scientific depth with business acumen. I’ve evaluated pipeline potential, led stakeholder engagement and market development for academic labs, startups, and research institutions.
In addition to my core scientific and strategic expertise, I have a growing proficiency in applying AI tools to support data analysis, literature mining, and market intelligence in the life sciences. I’ve explored how AI can enhance decision-making in areas like regulatory strategy, pipeline evaluation, and healthcare innovation, complementing my work in translational research and commercialization.
Whether advancing a novel imaging platform, supporting medical device development, or contributing to commercialization strategy for novel therapeutics, I bring clarity, creativity, and cross-disciplinary leadership to every initiative.
Let’s connect if you’re passionate about translational science, biomedical product development, or driving innovation in life sciences.
4 months ago | [YT] | 0
View 0 replies
AI Biopharma Playbook
🚨 BREAKING: Humacyte’s SYMVESS™ Gets FDA Approval | A New Era for Vascular Grafts Begins! 🚨
#Hemodialysis #MedicalBreakthrough #MedicalDevices
Humacyte has achieved a historic milestone! With FDA approval of SYMVESS™, a revolutionary acellular tissue-engineered vessel, the future of vascular trauma care—and beyond—just changed forever.
🔬 Why It Matters:
SYMVESS™ offers unmatched patency, infection resistance, and biocompatibility, setting a new standard for synthetic graft alternatives. Its ability to integrate into the body opens game-changing opportunities in:
✅ Peripheral Artery Disease (PAD)
✅ Hemodialysis Access (AV Fistulas & Grafts)
✅ Coronary Artery Bypass Grafting (CABG)
📊 Market Insight:
The vascular grafts market is projected to hit $2.8B by 2030 (CAGR: 7.2%), with regenerative medicine playing a central role.
🚀 Strategic Catalyst: Humacyte + AHAC Merger
This SPAC merger launched Humacyte on the Nasdaq (Ticker: HUMA), injecting capital and momentum to:
🔹 Fuel R&D and commercialization
🔹 Scale manufacturing and clinical trials
🔹 Expand into cell-based therapies and tissue engineering
🔹 Attract strategic partners and investors
💡 Why SYMVESS™ Stands Out:
✔️ Technological Edge – Outperforms synthetic grafts with reduced thrombosis & infection
✔️ Versatile Use Cases – Trauma, PAD, dialysis access, and potentially CABG
✔️ Regenerative Medicine Backbone – The future of vascular reconstruction is here.
🎯 What’s Next?
Humacyte is poised to redefine treatment paradigms across vascular surgery, nephrology, and cardiology.
👇 Watch, like, and subscribe to stay updated on the latest in biotech breakthroughs, regenerative medicine, and healthcare innovation.
#Humacyte #HUMA #SYMVESS #FDAApproval #RegenerativeMedicine #BiotechInnovation #TissueEngineering #TraumaCare #PeripheralArteryDisease #Hemodialysis #CoronaryArteryDisease #BiopharmaNews #SPACMerger #AHAC #MedicalDevices #HealthcareInnovation #FutureOfMedicine
4 months ago | [YT] | 1
View 0 replies
AI Biopharma Playbook
🌐 Are You Ready to Dive Into the Future?
Welcome to your go-to channel for the next generation of innovation. 🚀 Every week, we bring you deep dives into the most dynamic industries—AI, biotech, and beyond—through cutting-edge podcasts, expert interviews, and trend-driven videos.
🎯 Whether you're a biotech investor, venture capitalist, startup founder, corporate strategist, or simply passionate about the future of biotechnology, our content is designed to keep you ahead of the curve.
💡 Stay informed. Make smarter decisions. Be part of the next big thing.
🔔 Subscribe now and join a fast-growing community of innovators, investors, and industry leaders.
#AI #Biotech #Innovation #FutureTech #StartupNews #TechInvesting #NextGen
4 months ago | [YT] | 1
View 0 replies